Entity
  • Cephalgo

    Created in 2021
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    6,375
  • Activities

  • Entity types

  • Location

    8 Rue des Veaux, 67000 Strasbourg, France

    Strasbourg

    France

  • Employees

    Scale: 2-10

    Estimated: 3

  • Engaged corporates

    7
    3 5
  • Added in Motherbase

    1 year, 6 months ago
Description
  • Value proposition

    Innovations catalyze better mental healthcare

    Innovation for improving mental healthcare

Corporate interactions BETA
Corporate TypeTweets Articles
BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Other

31 Dec 2023


Maddyness
Maddyness
Media, Media Production
Maddyness
Media, Media Production
Other

9 Jan 2024


SEMIA
SEMIA
Startup accelerator & VC, Business Consulting and Services
SEMIA
Startup accelerator & VC, Business Consulting and Services
Other

31 May 2023


Région Grand Est
Région Grand Est
National and local authorities, Government Administration
Région Grand Est
National and local authorities, Government Administration
Other

31 May 2023


 EU Green Capital
EU Green Capital
European Union, Environmental Services
EU Green Capital
European Union, Environmental Services
Other

31 Aug 2022


KissKissBankBank
KissKissBankBank
Finance, Software Development
KissKissBankBank
Finance, Software Development
Other

4 Nov 2022


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking
Other

31 May 2023


Similar entities
AxisEntities
No similarities
Cephalgo
1 month, 1 week ago 24

🎄 Season's Greetings from the CEPHALGO team in Strasbourg! 🎊

As another year draws to a close, we want to thank our amazing community for being part of our journey toward better mental health care for all 🧠💚

We're incredibly grateful for the support from EIC Accelerator of European Innovation Council and SMEs Executive Agency (EISMEA), which strengthens our commitment to innovating in mental health technology 🚀 Also we would like to thank Penelope Stathoyannis, Matis Ringdal, Pierre BUCKEL, René NETHING, Thomas Lampert, Melissa McCradden, Mohamed Ragab, Clément Jacquemin, Cindy Sauvage, Amandine Quenson, Aude JEHL, Clémence Barloy, Burak Amil, Andrew Kenny, Derek Hill, Zeynep özge D., Eva Frigola-Capell, Alessandra Marenna, PhD, Pietro Carmellini, Alexandru Floares, Mattia Marco Caruson, the amazing consortium of OPADE project, Mélanie de Fays, Alicja Baryła, Ivan Fortuna, Tetiana Krupchenko, Virginie Cendret.PhD, Adrien Brazier, Nicolas SAPIN, Adeline ITZEL, Julie Hunzinger, Laura W., Prof. I-Mei Lin, Tomas Ros, Pasquale Arpaia, Nicola Moccaldi, Armida Mucci, Paul Risborough, and Chelsea Martinez for the most generous support we received this year. In 2024, we have the greatest honour to have top minds like Federico Zucchi, Constantinos Costopoulos, Yonghao Song, and Tim Chang. Your expertise and support drive our innovation forward.

Whether you're a healthcare professional, researcher, or someone interested in mental health innovation - we're here for you and excited to continue this important mission together in 2025! ✨

Wishing you all peaceful and rejuvenating holidays 🌟

#MentalHealth #Innovation #HealthTech #EUfunded #EICA

Cephalgo
3 months, 3 weeks ago 4 1

Today is World Mental Health Day and we are at Nuit de la sante mentale. A wonderful event for exchange and for promoting mental health care.

Many thanks for Pierre BUCKEL’s coordination 😊

#EICA #ADAPTE #mentalhealthcare #patientcentric

Cephalgo
6 months, 4 weeks ago 19

Great news! OPADE project has published an article in Brain Sciences. 📚🧠

The article entitled "Optimizing and Predicting Antidepressant Efficacy in Patients with Major Depressive Disorder Using Multi-Omics Analysis and the Opade AI Prediction Tools" has been published in the in the MDPI journal Brain Sciences.

This study addresses challenges in the diagnosis and treatment of major depressive disorder (MDD) by exploring early biomarkers and personalised treatment options. The approach involves correlating real-time electroencephalogram (EEG) and cognitive assessments of patients with analyses of biological samples. The study involves 350 patients aged 14-50 years in different countries and aims to improve the understanding and treatment of MDD.

Read the full article here! 👉 https://lnkd.in/eNc-BM_i

Thanks to the whole team for their hard work! 🙌

If you have questions or comments, feel free to share them - let's keep the research moving forward! 💡

#HorizonEU #OPADE

Cephalgo
7 months ago 17 1

🎉 Patent Approved 🎉

We're thrilled to announce that USPTO has officially granted us the patent for our innovative EEG eyewear adapter🎉

This discrete design, focusing on the temporal lobes, enables continuous EEG monitoring seamlessly integrated into daily life 👓 😎 This patent solidifies our advantage in this field and ensures that our technology remains protected and exclusive 💪

A heartfelt thank you to everyone involved in bringing this pioneering technology to life. Here’s to advancing the future of health monitoring with secure and accessible solutions! 🚀

#EEG #USPTO #PatentApproved

Cephalgo
7 months, 3 weeks ago 19 2

🎉 Our EEG tech just landed in Turkey as part of OPADE project!

Here’s a peek at the action from Medipol University hospital, featuring our "runway-ready" team 😎👩⚕️🧑⚕️ showing off live EEG with our discrete EEG device (an adapter to be mounted on any exiting eyewear) for continuous monitoring.


Huge thanks to the stars, Dr. Burak Amil, Cansu Coban, and their amazing teams at Medipol University hospital for a stellar welcome 🤩

Excited for what's next in revolutionizing psychiatric care! 🌟🧠

#OPADE #EEG #precision_psychiatry

Social network dynamics